Mon, Jan 26, 2015, 8:47 AM EST - U.S. Markets open in 43 mins.

Recent

% | $
Quotes you view appear here for quick access.

Cubist Pharmaceuticals Inc. Message Board

you are viewing a single comment's thread.

view the rest of the posts
  • stevencath@sbcglobal.net stevencath Sep 25, 2009 8:31 PM Flag

    This would be about the time Novartis would make a bid

    Navartis has now secured regulatory approval for---- CUBICIN---- in some additional countries, and is planning TO LAUNCH WITH THESE NEXT MONTHS----- Turkey, Russia,Mexico, Brazil, and Australia and New Zealand----Navartis should make at lot by this and a LOT more IF THEY BUY CUBIST PHARM. IN THE U.S.------------(CBST is going to make $1 Bill in the U.S.)CBST is working on other drugs to. Two phase II and two phase I drugs.

    SortNewest  |  Oldest  |  Most Replied Expand all replies
    • stevencath@sbcglobal.net stevencath Sep 26, 2009 2:28 PM Flag

      Novartis has now secured regulatory approval for CUBICIN in some additional countries and to LAUNCH NOW in Turkey,Russia,Mexico,Brazil and Australia and New Zealand----Novartis could make more by a lot------BUYING CUBIST PHARM.(CBST will in the outlook future sell CUBICIN $1 Bill in the U.S.)
      Also CBST is working on several other drugs 2 on phase I and 2 on phase II

 
CBST
101.940.00(0.00%)Jan 21 4:00 PMEST

Trending Tickers

i
Trending Tickers features significant U.S. stocks showing the most dramatic increase in user interest in Yahoo Finance in the previous hour over historic norms. The list is limited to those equities which trade at least 100,000 shares on an average day and have a market cap of more than $300 million.
Rock-Tenn Company
NYSEFri, Jan 23, 2015 4:00 PM EST
Five Prime Therapeutics, Inc.
NASDAQFri, Jan 23, 2015 4:00 PM EST
W.W. Grainger, Inc.
NYSEFri, Jan 23, 2015 4:01 PM EST